Van Eck Associates Corp. »

Intellia Therapeutics shares owned by Van Eck Associates Corp.

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Van Eck Associates Corp. from 13F filings

Historical chart of Van Eck Associates Corp. investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Van Eck Associates Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Van Eck Associates Corp.

Quarter filed Position value Share count Share price at filing
2025-09-30 $46k 2.6k 17.42
2025-06-30 $19k 2.0k 9.47
2025-03-31 $14k 2.0k 6.98
2024-12-31 $26k 2.2k 11.88
2024-09-30 $32k 1.6k 20.08
2024-06-30 $49k 2.2k 22.39
2024-03-31 $58k 2.1k 27.58
2023-12-31 $59k 1.9k 30.38
2023-09-30 $51k 1.6k 31.58
2023-06-30 $3.5M 85k 41.04
2023-03-31 $3.1M 84k 37.15
2022-12-31 $3.2M 94k 34.63
2022-09-30 $3.6M 63k 56.31
2022-06-30 $4.4M 85k 51.76
2022-03-31 $5.7M 78k 72.67
2021-12-31 $9.4M 80k 118.23
2021-09-30 $9.0M 67k 134.15